Our analysis also showed that anti-tumor effect of CALU is related to the activation of the ubiquitin system and inhibition of the Nucleotide-Binding Oligomerization Domain 1/2 (NOD1/2) and PKA pathways. This evidence concerns the gene NOD1 and neoplasm.